Search

everythinglearnresearchcommunity

for

Search:↓

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Combination therapy is more effective for prostate volumes over 60 ml.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Dutasteride may become the top choice for treating hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The combination treatment showed a higher response rate but no significant survival benefits.